Mutations in the OPA1 gene in humans most commonly lead to ADOA with loss of vision combined with neuromuscular multisystemic dysfunctions such as ataxia and peripheral neuropathy (5, 6). The gene discussed is OPA1; the disease is peripheral neuropathy.